J. Wo

发表

"Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer."

Jeffrey W. Clark, K. Lillemoe, A. Zhu, 2017, Annals of surgery.

Evaluating the combined effect of comorbidity and prostate-specific antigen kinetics on the risk of death in men after prostate-specific antigen recurrence.

A. Renshaw, A. D'Amico, P. Kantoff, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Irradiation of anatomically defined pelvic subsites and acute hematologic toxicity in anal cancer patients undergoing chemoradiation.

Jeffrey W. Clark, A. Niemierko, D. Ryan, 2017, Practical radiation oncology.

Pilot study on the impact of F18-labeled thymidine PET/CT on gross tumor volume identification and definition for pancreatic cancer.

M. Blake, A. Zhu, T. Hong, 2017, Practical radiation oncology.

Management implications of fluorodeoxyglucose positron emission tomography/magnetic resonance in untreated intrahepatic cholangiocarcinoma

D. Sahani, B. Rosen, M. Vangel, 2019, European Journal of Nuclear Medicine and Molecular Imaging.

The Impact of Positive Margins on Outcome Among Patients With Gastric Cancer Treated With Radiation

D. Ryan, E. Kwak, T. Hong, 2016, American journal of clinical oncology.

Advances in the Management of Gastric and Gastroesophageal Cancers

T. Hong, S. Kamran, J. Wo, 2016, Current Oncology Reports.

Gastrointestinal Cancer: Nonliver Proton Therapy for Gastrointestinal Cancers

J. Plastaras, J. Wo, F. Dionisi, 2014, Cancer journal.

Treating Oligometastatic Disease With SABR: More Than Just a Numbers Game?

D. Chang, E. Pollom, J. Wo, 2020, International journal of radiation oncology, biology, physics.

Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma.

Darrell, Janet, K., 2015, The oncologist.

Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer

S. Carter, E. V. Van Allen, J. Lennerz, 2019, Clinical Cancer Research.

Rectal and Colon Cancer: Radiation Therapy Planning

H. Mamon, S. Kamran, J. Wo, 2017 .

Randomized trials and new directions in gastrointestinal cancer.

T. Brunner, J. Cheng, Jeffrey Meyer, 2015, International journal of radiation oncology, biology, physics.

Association Between Very Small Tumor Size and Increased Cancer-Specific Mortality in Node-Positive Colon Cancer

P. Nguyen, D. Ryan, T. Hong, 2016, Diseases of the colon and rectum.

Feature ArticleOncology Scan – Gastrointestinal Cancer

C. Willett, Jeffrey Meyer, D. Chang, 2012 .

Cost-effectiveness of Short-Course Radiation Therapy vs Long-Course Chemoradiation for Locally Advanced Rectal Cancer

A. Raldow, D. Ryan, Aileen B Chen, 2019, JAMA network open.

Advancing Techniques of Radiation Therapy for Rectal Cancer.

T. Hong, J. Wo, S. Patel, 2016, Seminars in radiation oncology.

Mutational and Clinical Predictors of Pathologic Complete Response in the Treatment of Locally Advanced Rectal Cancer

Jeffrey W. Clark, A. Zhu, D. Ryan, 2014, Journal of Gastrointestinal Cancer.

Effect of Mismatch Repair Status on Outcome of Early-Stage Grade 1 to 2 Endometrial Cancer Treated With Vaginal Brachytherapy

A. Niemierko, E. Oliva, D. Spriggs, 2021, American journal of clinical oncology.

Key New Studies in Gastric and Esophageal Cancer.

T. Brunner, J. Cheng, Jeffrey Meyer, 2015, International journal of radiation oncology, biology, physics.

Phase II Study of Proton-Based Stereotactic Body Radiation Therapy for Liver Metastases: Importance of Tumor Genotype

Jeffrey W. Clark, B. Yeap, A. Zhu, 2017, Journal of the National Cancer Institute.

The Impact of Pathologic Complete Response in Patients with Neoadjuvantly Treated Locally Advanced Rectal Cancer—a Large Single-Center Experience

D. Berger, Jill N. Allen, L. Blaszkowsky, 2017, Journal of Gastrointestinal Surgery.

Oncology scan-novel treatment strategies for gastrointestinal cancers.

T. Brunner, J. Cheng, Jeffrey Meyer, 2014, International journal of radiation oncology, biology, physics.

Dosimetric predictors of nausea and vomiting: an exploratory analysis of a prospective phase I/II trial with neoadjuvant accelerated short-course radiotherapy and capecitabine for resectable pancreatic cancer

T. Hong, H. Mamon, Judy A. Adams, 2013, Journal of Radiation Oncology.

Impact of adjuvant therapy in patients with invasive intraductal papillary mucinous neoplasms of the pancreas.

Jeffrey W. Clark, K. Lillemoe, M. Mino‐Kenudson, 2020, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

An emerging role for radiation therapy in the treatment of hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

L. Dawson, A. Zhu, T. Hong, 2014, Surgical oncology clinics of North America.

Care Patterns and Overall Survival in Patients With Early-Onset Metastatic Colorectal Cancer

Jeffrey W. Clark, D. Ryan, T. Hong, 2021, JCO oncology practice.

Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients.

A. Viswanathan, J. Wo, 2009, International journal of radiation oncology, biology, physics.

Pancreatic ductal adenocarcinoma: tumour regression grading following neoadjuvant FOLFIRINOX and radiation

K. Lillemoe, D. Ting, V. Deshpande, 2020, Histopathology.

Chapter 52 – Anal Carcinoma

T. Hong, J. Wo, M. Callister, 2016 .

Intraoperative Radiation Therapy (IORT) for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (BR/LA PDAC) in the Era of Modern Neoadjuvant Treatment: Short-Term and Long-Term Outcomes

Jeffrey W. Clark, K. Lillemoe, T. Hong, 2019, Annals of Surgical Oncology.

Neoadjuvant versus Postoperative Chemoradiotherapy is Associated with Improved Survival for Patients with Resectable Gastric and Gastroesophageal Cancer

Jeffrey W. Clark, D. Ryan, T. Hong, 2021, Annals of Surgical Oncology.

Impact of 18F-FDG PET/MR based tumor delineation in radiotherapy planning for cholangiocarcinoma

O. Catalano, P. Heidari, J. Wo, 2021, Abdominal Radiology.

Clinical impact of PET/MR in treated colorectal cancer patients

Jeffrey W. Clark, B. Rosen, M. Vangel, 2019, European Journal of Nuclear Medicine and Molecular Imaging.

Integration of Systemic and Liver-Directed Therapies for Locally Advanced Hepatocellular Cancer: Harnessing Potential Synergy for New Therapeutic Horizons.

E. Koay, L. Goyal, E. Bent, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Treatment-associated remodeling of the pancreatic cancer endothelium at single-cell resolution

K. Jagadeesh, Jennifer Su, J. Wo, 2022, Frontiers in Oncology.

Delaying chemoradiation until after completion of adjuvant chemotherapy for pancreatic cancer may not impact local control.

A. Zhu, D. Ryan, E. Kwak, 2014, Practical radiation oncology.

The controversial role of chemoradiation for patients with locally advanced pancreatic cancer.

J. Faris, J. Wo, 2013, The oncologist.

Radiation recall associated with insulin growth factor 1R antibody.

D. Ryan, T. Hong, M. Kulke, 2011, Practical radiation oncology.

Liver Metastasis–Directed Ablative Radiotherapy in Pancreatic Cancer Offers Prolonged Time Off Systemic Therapy in Selected Patients

A. Niemierko, C. Hallemeier, T. Hong, 2021, Pancreas.

Intraoperative Radiation Mitigates the Effect of Microscopically Positive Tumor Margins on Survival Among Pancreatic Adenocarcinoma Patients Treated with Neoadjuvant FOLFIRINOX and Chemoradiation

K. Lillemoe, O. Catalano, V. Deshpande, 2021, Annals of Surgical Oncology.

Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma

Jeffrey W. Clark, K. Lillemoe, O. Catalano, 2020, Annals of surgery.

Tolerability and Long-term Outcomes of Dose-Painted Neoadjuvant Chemoradiation to Regions of Vessel Involvement in Borderline or Locally Advanced Pancreatic Cancer

Jeffrey W. Clark, K. Lillemoe, A. Niemierko, 2018, American journal of clinical oncology.

Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer A C

Jeffrey W. Clark, G. Boland, D. Ryan, 2021 .

Phase I study of neoadjuvant accelerated short course radiation therapy with photons and capecitabine for resectable pancreatic cancer.

K. Lillemoe, D. Ryan, E. Kwak, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Chemoradiation for Patients with Resected Biliary Tract Cancers in the Adjuvant Setting: Reply to a Letter to the Editor

E. Dee, J. Wo, M. Freret, 2020, Annals of Surgical Oncology.

ASO Author Reflections: Adjuvant Chemoradiation for Patients with Resected Biliary Tract Cancers

E. Dee, J. Wo, M. Freret, 2020, Annals of Surgical Oncology.

Evolution of the Role of Radiotherapy for Anal Cancer

E. Dee, J. Byrne, J. Wo, 2021, Cancers.

Using circulating tumor DNA (ctDNA) to predict surgical outcome and postoperative recurrence following neoadjuvant chemoradiation (CRT) for borderline resectable/locally advanced rectal cancer (LARC).

Jeffrey W. Clark, A. Zhu, D. Ryan, 2019, Journal of Clinical Oncology.

Using circulating tumor DNA (ctDNA) to predict surgical outcome after neoadjuvant chemoradiation for locally advanced pancreatic cancer (LAPC).

Jeffrey W. Clark, K. Lillemoe, A. Zhu, 2018 .

Gastric lymph node contouring atlas: A tool to aid in clinical target volume definition in 3-dimensional treatment planning for gastric cancer.

T. Hong, J. Wolfgang, H. Mamon, 2013, Practical radiation oncology.

Anal cancer: current and future treatment strategies

T. Hong, J. Wo, J. Chin, 2013 .

TGF-B1 inhibition with losartan in combination with FOLFIRINOX (F-NOX) in locally advanced pancreatic cancer (LAPC): Preliminary feasibility and R0 resection rates from a prospective phase II study.

Jeffrey W. Clark, K. Lillemoe, Y. Boucher, 2017 .

Optimal Neoadjuvant Strategies for Locally Advanced Rectal Cancer by Risk Assessment and Tumor Location.

A. Parikh, J. Wo, H. J. Roberts, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

Pencil Beam Scanning Proton Beam Chemoradiotherapy with 5-Fluorouracil and Mitomycin-C for Definitive Treatment of Carcinoma of the Anal Canal: A Multi-institutional Pilot Feasibility Study.

Jeffrey W. Clark, J. Metz, B. Yeap, 2019, International journal of radiation oncology, biology, physics.

Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529

Jeffrey W. Clark, D. Ryan, E. Kwak, 2017, Advances in radiation oncology.

Oncology ScandGastrointestinal Cancers

C. Willett, Jeffrey Meyer, D. Chang, 2013 .

Conditional Survival in Resected Pancreatic Ductal Adenocarcinoma Patients Treated with Total Neoadjuvant Therapy

Jeffrey W. Clark, K. Lillemoe, O. Catalano, 2021, Journal of Gastrointestinal Surgery.

Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment

Philip S. Yu, Martin J. Aryee, Ramkumar Veppathur Mohan, 2022, Nature Genetics.

Proton Beam Therapy for Esophageal Cancer

E. Dee, J. Wo, R. Rojo, 2022, Cancers.

ASO Author Reflections: High-Dose Radiation Offers Local Control for Inoperable Intrahepatic Cholangiocarcinoma

J. Wo, A. Smart, 2019, Annals of Surgical Oncology.

Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma

A. Zhu, D. Ryan, T. Hong, 2019, Annals of Surgical Oncology.

External beam accelerated partial-breast irradiation using 32 gy in 8 twice-daily fractions: 5-year results of a prospective study.

Barbara L. Smith, M. Specht, A. Recht, 2012, International journal of radiation oncology, biology, physics.

Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO).

Lawrence B Marks, Julia White, Benjamin D Smith, 2009, Journal of the American College of Surgeons.

Clinical needs assessment for sexual health among cancer patients receiving pelvic radiation: Implications for development of a radiation oncology sexual health clinic.

A. Niemierko, A. Zietman, J. Efstathiou, 2017, Practical radiation oncology.

Tumor microenvironment immune response in pancreatic ductal adenocarcinoma patients treated with neoadjuvant therapy.

Jeffrey W. Clark, K. Lillemoe, D. Ryan, 2020, Journal of the National Cancer Institute.

Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO).

T. Julian, T. Whelan, T. Buchholz, 2009, International journal of radiation oncology, biology, physics.

In Reply to Dr. Beal et al

T. Julian, T. Whelan, T. Buchholz, 2010 .

Case 19-2022: A 29-Year-Old Woman with Jaundice and Chronic Diarrhea.

A. Kambadakone, M. L. Zhang, J. Wo, 2022, The New England journal of medicine.

Dose--volume effects on patient-reported acute gastrointestinal symptoms during chemoradiation therapy for rectal cancer.

Ronald C. Chen, D. Ryan, T. Hong, 2012, International journal of radiation oncology, biology, physics.

Patient Survival With ypT0N+ Following Neoadjuvant Therapy in Rectal Cancer

J. Cusack, T. Hong, M. Qadan, 2021, Diseases of the colon and rectum.

Safety and Feasibility of Same-session Endoscopic Ultrasound-guided Biopsy and Fiducial Placement in Pancreatic Cancer

Jeffrey W. Clark, N. Nishioka, B. Jacobson, 2021 .

Current Practice Patterns in Locally Advanced Rectal Cancer at Academic Institutions: A National Survey Among Radiation Oncologists, Medical Oncologists, and Colorectal Surgeons.

A. Raldow, N. Sanford, J. Wo, 2022, Clinical colorectal cancer.

Complications of pelvic radiation in patients treated for gynecologic malignancies

A. V. von Keudell, N. Horowitz, P. Konstantinopoulos, 2014, Cancer.

Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX

Jeffrey W. Clark, K. Lillemoe, D. Ryan, 2019, Annals of surgery.

Single-nucleus and spatial transcriptomics of archival pancreatic cancer reveals multi-compartment reprogramming after neoadjuvant treatment

Ramkumar Veppathur Mohan, Samouil L. Farhi, A. Regev, 2020, bioRxiv.

Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical Trial.

Jeffrey W. Clark, K. Lillemoe, R. Jain, 2019, JAMA oncology.

Mutational analysis and clinical correlation of metastatic colorectal cancer

A. Iafrate, D. Dias-Santagata, A. Zhu, 2014, Cancer.

Radiation Therapy Enhances Immunotherapy Response in Microsatellite-stable Colorectal and Pancreatic Adenocarcinoma in a Phase II Trial

Jeffrey W. Clark, N. Hacohen, B. Yeap, 2021, Nature Cancer.

Circulating Oncometabolite 2-Hydroxyglutarate Is a Potential Surrogate Biomarker in Patients with Isocitrate Dehydrogenase-Mutant Intrahepatic Cholangiocarcinoma

Jeffrey W. Clark, A. Iafrate, D. Christiani, 2014, Clinical Cancer Research.

Circulating Oncometabolite 2-Hydroxyglutarate Is a Potential Surrogate Biomarker in Patients with Isocitrate Dehydrogenase-Mutant Intrahepatic Cholangiocarcinoma

Jeffrey W. Clark, A. Iafrate, D. Christiani, 2014, Clinical Cancer Research.

Pan-cancer Transcriptomic Predictors of Perineural Invasion Improve Occult Histopathologic Detection

A. Niemierko, T. Jacks, M. Mino‐Kenudson, 2021, Clinical Cancer Research.

Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer

Jeffrey W. Clark, B. Miao, G. Boland, 2021, Clinical Cancer Research.

Therapeutic avenues for cancer neuroscience: translational frontiers and clinical opportunities.

William L. Hwang, P. Wen, T. Jacks, 2022, The Lancet. Oncology.

Improving staging of rectal cancer in the pelvis: the role of PET/MRI

Jeffrey W. Clark, B. Rosen, A. Soricelli, 2020, European Journal of Nuclear Medicine and Molecular Imaging.

Rectal and Colon Cancer: Background and Clinical Evidence

H. Mamon, S. Kamran, J. Wo, 2017 .

Treatment of Stage II–III Rectal Cancer Patients

T. Hong, J. Wo, Miranda B. Kim, 2013, Current Oncology Reports.

Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical Trial

Jeffrey W. Clark, K. Lillemoe, B. Yeap, 2018, JAMA oncology.

Chemoradiation therapy: localized esophageal, gastric, and pancreatic cancer.

L. Kachnic, T. Hong, H. Mamon, 2013, Surgical oncology clinics of North America.

A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma.

Jeffrey W. Clark, R. Jain, Y. Boucher, 2014, International journal of radiation oncology, biology, physics.

FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience.

Jeffrey W. Clark, K. Lillemoe, D. Sahani, 2013, The oncologist.

Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers

Jeffrey W. Clark, A. Iafrate, D. Dias-Santagata, 2020, Clinical Cancer Research.

Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers

Jeffrey W. Clark, T. Golub, G. Getz, 2019, Nature Medicine.

Why does androgen deprivation enhance the results of radiation therapy?

A. Zietman, J. Wo, 2008, Urologic oncology.

Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal Cancer

Jeffrey W. Clark, A. Zhu, J. Lennerz, 2021, JCO precision oncology.

Response prediction of neoadjuvant chemoradiation therapy in locally advanced rectal cancer using CT-based fractal dimension analysis

A. Kambadakone, Y. Noda, B. Ganeshan, 2021, European Radiology.

Targeted therapies with chemoradiation in esophageal cancer: development and future directions.

E. Kwak, T. Hong, J. Wo, 2013, Seminars in radiation oncology.

Radiation Induced Checkpoint Immunotherapy Response in Refractory Colorectal and Pancreatic Adenocarcinoma

Jeffrey W. Clark, N. Hacohen, B. Yeap, 2020 .

Liver reirradiation for patients with hepatocellular carcinoma and liver metastasis.

Jeffrey W. Clark, A. Zhu, A. Raldow, 2018, Practical radiation oncology.

Refusal of surgery for colon cancer: Sociodemographic disparities and survival implications among US patients with resectable disease.

J. Cusack, M. Qadan, R. Goldstone, 2020, American journal of surgery.

Cardiac toxicity observed in association with high-dose cyclophosphamide-based chemotherapy for metastatic breast cancer.

A. Troxel, C. Jacobson, C. Hesdorffer, 2004, Breast.

Supportive Oncology Care at Home Intervention for Patients With Pancreatic Cancer

J. Temel, D. Ryan, D. Ting, 2021, JCO oncology practice.

Results and Molecular Correlates from a Pilot Study of Neoadjuvant Induction FOLFIRINOX Followed by Chemoradiation and Surgery for Gastroesophageal Adenocarcinomas

Jeffrey W. Clark, M. Mino‐Kenudson, R. Heist, 2020, Clinical Cancer Research.

The Tipping Point: Key Oncologic Imaging Findings Resulting in Critical Changes in the Management of Malignant Tumors of the Gastrointestinal Tract.

R. Nipp, M. Qadan, R. Uppot, 2019, Current problems in diagnostic radiology.

Association Between Very Small Tumor Size and Decreased Overall Survival in Node-Positive Pancreatic Cancer

T. Hong, H. Mamon, R. Nipp, 2017, Annals of Surgical Oncology.

Total Neoadjuvant TherapyWith FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma A Phase 2 Clinical Trial

Jeffrey W. Clark, K. Lillemoe, B. Yeap, 2018 .

Predictors of Early Mortality After Surgical Resection of Pancreatic Adenocarcinoma in the Era of Neoadjuvant Treatment

Jeffrey W. Clark, K. Lillemoe, D. Ryan, 2017, Pancreas.

Long-Term Outcomes and Prognostic Factors for Patients With Unresectable Locally Advanced Pancreatic Cancer Treated With Intraoperative Radiotherapy at the Massachusetts General Hospital , 1978 to 2010

K. Lillemoe, C. Willett, D. Ryan, 2013 .

Impact of age and comorbidities on the treatment of gastrointestinal malignancies.

L. Kachnic, T. Hong, J. Wo, 2012, Seminars in radiation oncology.

Dosimetric analysis and normal tissue complication probability modeling of Child-Pugh score and Albumin-Bilirubin grade increase after hepatic irradiation.

K. Brock, B. Yeap, I. El Naqa, 2020, International journal of radiation oncology, biology, physics.

Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival.

Jeffrey W. Clark, B. Yeap, A. Zhu, 2019, International journal of radiation oncology, biology, physics.

Liver-Directed Radiotherapy for Hepatocellular Carcinoma

A. Zhu, T. Hong, J. Wo, 2016, Liver Cancer.

Radiation therapy for liver tumors: ready for inclusion in guidelines?

Andrew X. Zhu, Laura A. Dawson, L. Dawson, 2014, The oncologist.

Stereotactic body radiation therapy for primary liver tumors: An effective liver‐directed therapy in the toolbox

J. Wo, H. J. Roberts, H. Roberts, 2021, Cancer.

Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Lipika Goyal, Christopher H Crane, Edgar Ben-Josef, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Palliative external beam radiotherapy for hepatocellular carcinoma with right atrial tumor thrombus.

A. Zhu, T. Hong, M. Qadan, 2020, Practical radiation oncology.

Patterns of Care and Outcomes of Definitive External Beam Radiotherapy and Radioembolization for Localized Hepatocellular Carcinoma

A. Niemierko, B. Mahal, A. Zhu, 2019, American journal of clinical oncology.

Clinical impact of PET/MRI in oligometastatic colorectal cancer

Jeffrey W. Clark, M. Vangel, O. Catalano, 2021, British Journal of Cancer.

A Combination of Biochemical and Pathological Parameters Improves Prediction of Postresection Survival After Preoperative Chemotherapy in Pancreatic Cancer

Jeffrey W. Clark, K. Lillemoe, M. Büchler, 2020, Annals of surgery.

Effect of very small tumor size on cancer-specific mortality in node-positive breast cancer.

N. Lin, B. Neville, Nancy U Lin, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Are Staging Computed Tomography (CT) Scans of the Chest Necessary in Pancreatic Adenocarcinoma?

Jeffrey W. Clark, K. Lillemoe, P. Pandharipande, 2018, Annals of Surgical Oncology.

Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy.

Phoebe E. Freer, Barbara L. Smith, A. Niemierko, 2012, International journal of radiation oncology, biology, physics.

Local Therapy Options for Recurrent Rectal and Anal Cancer: Current Strategies and New Directions

N. Sanford, C. Eyler, E. Dee, 2019, Current Colorectal Cancer Reports.

Clinical staging in pancreatic adenocarcinoma underestimates extent of disease.

K. Lillemoe, D. Ryan, T. Hong, 2020, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Standard fractionation external beam radiotherapy with and without intraoperative radiotherapy for locally recurrent rectal cancer: the role of local therapy in patients with a high competing risk of death from distant disease.

Jeffrey W. Clark, A. Kishan, D. Ryan, 2017, The British journal of radiology.

Intraoperative Radiotherapy in the Era of Intensive Neoadjuvant Chemotherapy and Chemoradiotherapy for Pancreatic Adenocarcinoma

Jeffrey W. Clark, K. Lillemoe, D. Ryan, 2016, American journal of clinical oncology.

Patterns of Failure and the Need for Biliary Intervention in Resected Biliary Tract Cancers After Chemoradiation

Jeffrey W. Clark, A. Zhu, A. Raldow, 2020, Annals of Surgical Oncology.

Enrichment of HER2 Amplification in Brain Metastases from Primary Gastrointestinal Malignancies.

Jeffrey W. Clark, A. Iafrate, W. Curry, 2018, The oncologist.

Proton beam radiotherapy for anal and rectal cancers.

J. Wo, E. Vaios, 2020, Journal of gastrointestinal oncology.

Chemoradiation-related lymphopenia and its association with survival in patients with squamous cell carcinoma of the anal canal.

Jeffrey W. Clark, D. Ryan, T. Hong, 2020, The oncologist.

Irradiation of FDG-PET-Defined Active Bone Marrow Subregions and Acute Hematologic Toxicity in Anal Cancer Patients Undergoing Chemoradiation.

A. Niemierko, K. Jee, T. Hong, 2015, International journal of radiation oncology, biology, physics.

Differential Association Between Circulating Lymphocyte Populations With Outcome After Radiation Therapy in Subtypes of Liver Cancer.

Jeffrey W. Clark, T. Bortfeld, R. Jain, 2018, International journal of radiation oncology, biology, physics.

Sexual Function, Quality of Life, and Mood After Radiation Therapy in Patients with Anal Cancer

D. Ryan, T. Hong, N. Horick, 2019, Journal of Gastrointestinal Cancer.

Predictors of Lymph Node Metastasis in Western Early Gastric Cancer

D. Rattner, E. Kwak, T. Hong, 2016, Journal of Gastrointestinal Surgery.

Oncology scan--gastrointestinal cancers.

C. Willett, D. Chang, B. Czito, 2012, International journal of radiation oncology, biology, physics.

Underlying Bias in the Treatment of Pancreatic Cancer

K. Lillemoe, M. Qadan, C. Ferrone, 2021, Annals of surgery.

Proof of concept of the abscopal effect in MSS GI cancers: A phase 2 study of ipilimumab and nivolumab with radiation in metastatic pancreatic and colorectal adenocarcinoma.

B. Yeap, A. Zhu, D. Ryan, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase II study of ipilimumab and nivolumab with radiation in metastatic pancreatic adenocarcinoma.

Jeffrey W. Clark, D. Ryan, T. Hong, 2019, Journal of Clinical Oncology.

Treatment of Localized Anal Cancer: Chemoradiotherapy

J. Byrne, J. Wo, 2019, Anal Cancer.

Arterial involvement and resectability scoring system to predict R0 resection in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation therapy

Jeffrey W. Clark, K. Lillemoe, A. Kambadakone, 2021, European Radiology.

Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline.

Charles R. Thomas, A. Raldow, E. Ruíz-García, 2020, Practical radiation oncology.

Socioeconomic determinants of the surgical treatment of colorectal liver metastases.

T. Hong, Hang Lee, M. Qadan, 2020, American journal of surgery.

Impact of Treatment Sequencing on Survival for Patients with Locally Advanced Gastric Cancer

Jeffrey W. Clark, C. L. Costantino, T. Hong, 2021, Annals of Surgical Oncology.

Patterns of Care for Stage II-III Rectosigmoid Cancers in the United States, 2004-2015

M. Folkert, T. Hong, T. Aguilera, 2020, American journal of clinical oncology.

T3N0 rectal cancer: radiation for all?

D. Ryan, T. Hong, H. Mamon, 2011, Seminars in radiation oncology.

Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer.

Martin J. Aryee, Linda T. Nieman, Jeffrey W. Clark, 2022, Cancer discovery.

Optimizing adjuvant treatment decisions for stage t2 rectal cancer based on mesorectal node size: a decision analysis.

M. Harisinghani, Jonathan D. Eisenberg, G. Gazelle, 2013, Academic radiology.

The results of concurrent chemo‐radiotherapy for recurrence after treatment with bacillus Calmette‐Guérin for non‐muscle‐invasive bladder cancer: is immediate cystectomy always necessary?

A. Zietman, W. Shipley, N. Heney, 2009, BJU international.

A phase II study of ipilimumab and nivolumab with radiation in microsatellite stable (MSS) metastatic colorectal adenocarcinoma (mCRC).

Jeffrey W. Clark, B. Yeap, A. Zhu, 2019, Journal of Clinical Oncology.

Long‐term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer

Jeffrey W. Clark, A. Niemierko, A. Zhu, 2012, Cancer.

Tolerability, Attrition Rates, and Survival Outcomes of Neoadjuvant FOLFIRINOX for Non-Metastatic Pancreatic Adenocarcinoma: Intent-to-Treat Analysis.

Jeffrey W. Clark, K. Lillemoe, D. Ryan, 2022, Journal of the American College of Surgeons.

A pilot study of durvalumab/tremelimumab (durva/treme) and radiation (XRT) for metastatic biliary tract cancer (mBTC): Preliminary safety and efficacy.

Jeffrey W. Clark, J. Meyerhardt, B. Yeap, 2020 .

Gallbladder toxicity and high-dose ablative-intent radiation for liver tumors: Should we constrain the dose?

A. Niemierko, A. Zhu, T. Hong, 2017, Practical radiation oncology.

Elective nodal irradiation with simultaneous integrated boost stereotactic body radiotherapy for pancreatic cancer: Analyses of planning feasibility and geometrically driven DVH prediction model

T. Hong, J. Wolfgang, A. Nakamura, 2019, Journal of applied clinical medical physics.

Stereotactic body radiation therapy (SBRT) for pancreatic and non-hepatobiliary gastrointestinal (GI) malignancies

T. Hong, J. Phillips, J. Wo, 2013, Journal of Radiation Oncology.

Potentially curative combination of TGF-b1 inhibitor losartan and FOLFIRINOX (FFX) for locally advanced pancreatic cancer (LAPC): R0 resection rates and preliminary survival data from a prospective phase II study.

Jeffrey W. Clark, K. Lillemoe, R. Jain, 2018 .

High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy

Jeffrey W. Clark, D. Ryan, D. Ting, 2019, The oncologist.

The association between biological subtype and isolated regional nodal failure after breast-conserving therapy.

Barbara L. Smith, J. Bellon, M. Gadd, 2009, International journal of radiation oncology, biology, physics.

Impact of Postoperative Complication and Completion of Multimodality Therapy on Survival in Patients Undergoing Gastrectomy for Advanced Gastric Cancer.

Jeffrey W. Clark, T. Hong, E. Roeland, 2020, Journal of the American College of Surgeons.

Impact of intravenous contrast enhancement phase on target definition for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (IHC): Observations from patients enrolled on a prospective phase 2 trial.

A. Zhu, P. Hahn, T. Hong, 2016, Practical radiation oncology.

Primary tumor sidedness is an independent prognostic marker for survival in metastatic colorectal cancer: Results from a large retrospective cohort with mutational analysis

Jeffrey W. Clark, A. Iafrate, A. Zhu, 2018, Cancer medicine.

Clinical and treatment factors associated with vaginal stenosis after definitive chemoradiation for anal canal cancer.

A. Niemierko, Jacqueline A. Nyamwanda, D. Ryan, 2015, Practical radiation oncology.

Phase Ib study of neoadjuvant chemoradiation (CRT) with midostaurin, 5-fluorouracil (5-FU) and radiation (XRT) for locally advanced rectal cancer: Sensitization of RAS mutant tumors.

Jeffrey W. Clark, D. Rattner, A. Zhu, 2018 .

Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Versus the Standard of Care Imaging in the Diagnosis of Peritoneal Carcinomatosis

Jeffrey W. Clark, B. Rosen, O. Catalano, 2022, Annals of surgery.

Gender, Productivity, and Philanthropic Fundraising in Academic Oncology.

J. Silver, J. Loeffler, N. Tarbell, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

Addition of losartan to FOLFIRINOX and chemoradiation reduces immunosuppression-associated genes, Tregs and FOXP3+ cancer cells in locally advanced pancreatic cancer.

Jeffrey W. Clark, R. Jain, Y. Boucher, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.

RISE: An Equity and Inclusion-based Virtual Pipeline Program for Medical Students Underrepresented in Medicine

A. Zietman, A. Hirsch, J. Wo, 2021 .

Dosimetric Analysis of Proton Pencil Beam Scanning Radiation Therapy Versus Dose Painted Intensity Modulated Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal

H. Kooy, T. Hong, J. Wo, 2014 .

Radiotherapy in setting of collagen vascular disease.

A. Taghian, J. Wo, 2007, International journal of radiation oncology, biology, physics.

A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.

P. Catalano, R. Bueno, P. Enzinger, 2017, Diseases of the esophagus.

Therapy-associated remodeling of pancreatic cancer revealed by single-cell spatial transcriptomics and optimal transport analysis

T. Jacks, R. Weissleder, M. Mino‐Kenudson, 2023, bioRxiv.

Author Correction: Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers

Jeffrey W. Clark, T. Golub, G. Getz, 2019, Nature Medicine.

A pilot feasibility study of definitive concurrent chemoradiation with pencil beam scanning proton beam in combination with 5-fluorouracil and mitomycin-c for carcinoma of the anal canal.

Jeffrey W. Clark, J. Metz, B. Yeap, 2018 .

A multicenter, randomized phase II study of total neoadjuvant therapy (TNT) with FOLFIRINOX (FFX) and SBRT, with or without losartan (L) and nivolumab (N) in borderline resectable (BR) and locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC).

B. Yeap, D. Ryan, D. Ting, 2023, Journal of Clinical Oncology.

Addition of losartan to FOLFORINOX and chemoradiation downregulates pro-invasion and immunosuppression-associated genes in locally advanced pancreatic cancer

Jeffrey, Y. Boucher, M. Mino‐Kenudson, 2022, medRxiv.

Minimal Residual Disease Detection using a Plasma-Only Circulating Tumor DNA Assay in Colorectal Cancer Patients

Jeffrey W. Clark, Qadan, Ariel, 2021 .

Portal Vein or Superior Mesenteric Vein Thrombosis with Dose-Escalated Radiation for Borderline or Locally Advanced Pancreatic Cancer.

K. Lillemoe, A. Niemierko, D. Ryan, 2023, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.

Predictive Modeling of Survival and Toxicity in Patients With Hepatocellular Carcinoma After Radiotherapy

I. El Naqa, H. Paganetti, T. Hong, 2022, JCO clinical cancer informatics.